Promyelocytic Leukemia Protein Potently Restricts Human Cytomegalovirus Infection in Endothelial Cells

Int J Mol Sci. 2022 Oct 8;23(19):11931. doi: 10.3390/ijms231911931.

Abstract

PML nuclear bodies (PML-NBs) are dynamic macromolecular complexes that mediate intrinsic immunity against viruses of different families, including human cytomegalovirus (HCMV). Upon HCMV infection, PML-NBs target viral genomes entering the nucleus and restrict viral immediate-early gene expression by epigenetic silencing. Studies from several groups performed in human fibroblast cells have shown that the major PML-NB components PML, Daxx, Sp100 and ATRX contribute to this repression in a cooperative manner. Their role for HCMV restriction in endothelial cells, however, has not yet been characterized although infected endothelium is thought to play a crucial role for HCMV dissemination and development of vascular disease in vivo. Here, we use conditionally immortalized umbilical vein endothelial cells (HEC-LTT) as a cell culture model to elucidate the impact of PML-NB proteins on lytic HCMV infection. Depletion of individual PML-NB proteins by lentiviral transduction showed a particularly strong antiviral effect of PML in HEC-LTT, compared to human fibroblasts. A closer characterization of this antiviral function revealed that PML may not only effectively inhibit HCMV immediate-early gene expression but also act at later steps of the viral replication cycle. At contrast, we surprisingly noted an antiviral behavior of Daxx in complementary approaches: Depletion of Daxx resulted in decreased viral gene expression, while overexpression of Daxx promoted HCMV infection. In summary, our data demonstrate a cell type-specific effect of PML-NB components on lytic HCMV infection and suggest an important role of PML in the inhibition of HCMV dissemination through infected endothelial cells.

Keywords: Daxx; HCMV; HEC-LTT; PML; PML nuclear bodies; cytomegalovirus; endothelial cells.

MeSH terms

  • Antiviral Agents / metabolism
  • Cytomegalovirus
  • Cytomegalovirus Infections*
  • Endothelial Cells / metabolism
  • Herpesviridae Infections*
  • Humans
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism
  • Promyelocytic Leukemia Protein* / genetics
  • Promyelocytic Leukemia Protein* / metabolism
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • Virus Replication

Substances

  • Antiviral Agents
  • Nuclear Proteins
  • Promyelocytic Leukemia Protein
  • Transcription Factors
  • PML protein, human